학술논문

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Document Type
Article
Author
Paz-Ares, LuisDvorkin, MikhailChen, YuanbinReinmuth, NielsHotta, KatsuyukiTrukhin, DmytroStatsenko, GalinaHochmair, Maximilian JÖzgüroğlu, MustafaJi, Jun HoVoitko, OleksandrPoltoratskiy, ArtemPonce, SantiagoVerderame, FrancescoHavel, LiborBondarenko, IgorKazarnowicz, AndrzejLosonczy, GyörgyConev, Nikolay VArmstrong, JonByrne, NatalieShire, NorahJiang, HaiyiGoldman, Jonathan WBatagelj, EmilioCasarini, IgnacioPastor, Anea VivianaSena, Susana NoemiZarba, Juan JoseBurghuber, OttoHartl, SylviaHochmair, Maximilian JLamprecht, BerndStudnicka, MichaelAlberto Schlittler, LuisAugusto Martinelli de Oliveira, FabricioCalabrich, AknarColagiovanni Girotto, GustavoDos Reis, PeoFausto Nino Gorini, CarlosRafael Martins De Marchi, PeoSerodio da Rocha Baldotto, ClarissaSette, ClaudiaZukin, MauroConev, Nikolay VDudov, AssenIlieva, RumyanaKoynov, KrassimirKrasteva, RositsaTonev, IvanValev, SpartakVenkova, VioletkaBi, MinghongChen, ChengshuiChen, YuanChen, ZhendongFang, JianFeng, JifengHan, ZhigangHu, JieHu, YiLi, WeiLiang, ZonganLin, ZhongMa, RuiMa, ShenglinNan, KejunShu, YongqianWang, KaiWang, MengzhaoWu, GangYang, NongYang, ZhixiongZhang, HelongZhang, WeiZhao, JunZhao, YanqiuZhou, CaicunZhou, JianyingZhou, XiangdongHavel, LiborKolek, VitezslavKoubkova, LeonaRoubec, JaromirSkrickova, JanaZemanova, MiladaChouaid, ChristosHilgers, WernerLena, HervéMoro-Sibilot, DenisRobinet, GillesSouquet, Pierre-JeanAlt, JürgenBischoff, HelgeGrohe, ChristianLaack, EckartLang, SusannePanse, JensReinmuth, NielsSchulz, ChristianBogos, KrisztinaCsánky, EszterFülöp, AneaHorváth, ZsoltKósa, JuditLaczó, IbolyaLosonczy, GyörgyPajkos, GáborPápai, ZsuzsannaPápai Székely, ZsoltSárosi, VeronikaSomfay, AttilaSomogyiné Ezer, ÉvaTelekes, AnásBar, JairGottfried, MayaHeching, Norman IsaacZer Kuch, AlonaBartolucci, RobertaBettini, Anna CeciliaDelmonte, AngeloGarassino, Marina ChiaraMinelli, MauroRoila, FaustoVerderame, FrancescoAtagi, ShinjiAzuma, KoichiGoto, HisatsuguGoto, KoichiHara, YuHayashi, HidetoshiHida, ToyoakiHotta, KatsuyukiKanazawa, KenyaKanda, ShintaroKim, Young HakKuyama, ShoichiMaeda, TadashiMorise, MasahiroNakahara, YasuharuNishio, MakotoNogami, NaoyukiOkamoto, IsamuSaito, HaruhiroShinoda, MasahiroUmemura, ShigekiYoshida, TatsuyaClaessens, NielsCornelissen, RobinHeniks, LizzaHiltermann, JeroenSmit, EgbertStaal van den Brekel, AgnesKazarnowicz, AndrzejKowalski, DariuszMańdziuk, SlawomirMróz, RobertWojtukiewicz, MarekCiuleanu, TudorGanea, DoinaUngureanu, AneiDvorkin, MikhailLuft, AlexanderMoiseenko, VladimirPoltoratskiy, ArtemSakaeva, DinaSmolin, AlexeyStatsenko, GalinaVasilyev, AlexanderVladimirova, LyubovAnasina, IgorChovanec, JozefDemo, PavolGodal, RobertKasan, PeterStresko, MarianUrda, MichalCho, Eun KyungJi, Jun HoKim, Joo-HangKim, Sang-WeLee, Gyeong-WonLee, Jong-SeokLee, Ki HyeongLee, Kyung HeeLee, Yun GyooAmelia Insa Molla, MariaDomine Gomez, ManuelIgnacio Delgado Mingorance, JuanIsla Casado, DoloresLopez Brea, MartaMajem Tarruella, MargaritaMorán Bueno, TeresaNavarro Mendivil, AlejanoPaz-Ares Rodríguez, LuisPonce Aix, SantiagoRosario Garcia Campelo, MariaChang, Gee-ChenChen, Yen-HsunChiu, Chao-HuaHsia, Te-ChunLee, Kang-YunLi, Chien-TeWang, Chin-ChouWei, Yu-FengWu, Shang-YinAlacacıoğlu, AhmetÇiçin, IrfanDemirkazik, AhmetErman, MustafaGöksel, TuncayÖzgüroğlu, MustafaAdamchuk, HryhoriyBondarenko, IgorKolesnik, OleksiiKryzhanivska, AnnaOstapenko, YurivShevnia, SerhiiShparyk, YaroslavTrukhin, DmytroUrsol, GrygoriiVoitko, NataliiaVoitko, OleksandrVynnychenko, IhorBabu, SunilChen, YuanbinChiang, AnneChua, WinstonDakhil, ShakerDowlati, AfshinGoldman, Jonathan WHaque, BasirJamil, RodneyKnoble, JeannaLakhanpal, ShailenaMi, KailhongNikolinakos, PetrosPowell, StevenRoss, HelenSchaefer, EricSchneider, JeffreySpahr, JosephSpigel, DavidStilwill, JosephSumey, ChristopherWilliamson, Michael
Source
The Lancet; November 2019, Vol. 394 Issue: 10212 p1929-1939, 11p
Subject
Language
ISSN
01406736; 1474547X
Abstract
Most patients with small-cell lung cancer (SCLC) have extensive-stage disease at presentation, and prognosis remains poor. Recently, immunotherapy has demonstrated clinical activity in extensive-stage SCLC (ES-SCLC). The CASPIAN trial assessed durvalumab, with or without tremelimumab, in combination with etoposide plus either cisplatin or carboplatin (platinum–etoposide) in treatment-naive patients with ES-SCLC.